Further Characterization and Validation of Monoclonal Antibodies to Study Respiratory
Contract Overview
Contract Amount: $1,084,824 ($1.1M)
Contractor: Ampersand Biosciences LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2024-09-30
End Date: 2026-09-29
Contract Duration: 729 days
Daily Burn Rate: $1.5K/day
Official Description: FURTHER CHARACTERIZATION AND VALIDATION OF MONOCLONAL ANTIBODIES TO STUDY RESPIRATORY
Place of Performance
Location: New York, 12945
State: New York Government Spending